| |
| |
|
| Insider
Information: |
Kenyon Lawrence A |
| Relationship: |
CEO, Pres, CFO, Treas ... |
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
33,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$133,239 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,263 |
|
|
| Total
Value |
$133,239 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
Former EVP and CFO |
2010-08-02 |
14,337 |
2009-01-08 |
0 |
Premium* |
|
|
Outlook Therapeutics Inc |
OTLK |
CEO, Pres, CFO, Treas ... |
2021-04-20 |
18,926 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OTLK |
Outlook Therapeutics Inc |
CEO, Pres, CFO, Treas & Secy |
• • – |
2021-04-20 |
4 |
B |
$1.83 |
$18,300 |
D/D |
10,000 |
18,926 |
2.81 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CEO, Pres, CFO, Treas & Secy |
• • – |
2019-09-18 |
4/A |
S |
$1.70 |
$2,295 |
D/D |
(1,350) |
8,926 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CEO, Pres, CFO, Treas & Secy |
• • – |
2019-09-18 |
4 |
S |
$1.70 |
$2,295 |
D/D |
(1,350) |
80,863 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CEO, Pres, CFO, Treas & Secy |
• • – |
2019-02-07 |
4 |
B |
$0.90 |
$22,380 |
D/D |
25,000 |
82,213 |
2.81 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CEO, Pres, CFO, Treas & Secy |
• • – |
2018-09-18 |
4 |
S |
$0.87 |
$8,807 |
D/D |
(10,100) |
57,213 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CFO and Secretary |
• – – |
2017-12-22 |
4 |
S |
$1.13 |
$29,566 |
D/D |
(26,165) |
67,313 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CFO and Secretary |
• – – |
2016-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
93,478 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
CFO and SecretaryOfficer |
• – – |
2016-05-12 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
43,478 |
|
- |
|
| OTLK |
Outlook Therapeutics Inc |
CFO and SecretaryOfficer |
• – – |
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,478 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Former EVP and CFO |
– – – |
2010-08-02 |
4 |
D |
$26.90 |
$169,793 |
D/D |
(6,312) |
14,337 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
• – – |
2010-03-03 |
4 |
S |
$25.19 |
$540,355 |
D/D |
(21,439) |
20,649 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
• – – |
2010-03-03 |
4 |
OE |
$13.06 |
$279,993 |
D/D |
21,439 |
42,088 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
• – – |
2010-01-08 |
4 |
D |
$25.88 |
$23,214 |
D/D |
(897) |
20,649 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
• – – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,826 |
21,546 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP Finance-Par Pharmaceutical |
– – – |
2009-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,720 |
10,720 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
